Literature DB >> 33277271

Mucin as a Functional Niche is a More Important Driver of in Vitro Gut Microbiota Composition and Functionality than Supplementation of Akkermansia m uciniphila.

Florence Van Herreweghen1, Kim De Paepe1, Massimo Marzorati1,2, Tom Van de Wiele3.   

Abstract

IMPORTANCE SECTION Research into identification of biomarkers for gut health and ways to modulate the microbiota composition and activity to improve health, has put Akkermansia muciniphila in the spotlight. As a mucin degrader, A. muciniphila colonizes the interesting but not-fully described host-glycan degradation niche., . Plenty of research concerning A. muciniphila has been done, but little is known about its behavior in the complex microbial ecosystem in the colon, about the potential role of mucins to influence A. muciniphila behavior and the impact of its probiotic administration on the microbial ecosystem.This study aimed at investigating the impact of A. muciniphila administration on the endogenous community while also taking into account its nutritional specificity. As such, the effect of A.mucinihpila administration was investigated with and without addition of mucin. This allowed us to elucidate the importance of mucin presence to modulate the efficiency of the probiotic supplementation with A. muciniphila Akkermansia muciniphila is an abundantly present commensal mucin degrading gut bacterium (1 - 4%) , widely distributed among healthy individuals. It has been positioned as a health biomarker and is currently explored as a biotherapeutic agent and next generation probiotic. Preliminary and ongoing research is mostly based on in vivo mouse models and human intervention trials. While these allow the assessment of physiologically relevant endpoints, the analysis of fecal samples presents limitations with respect to the in-depth mechanistic characterization of Akkermansia effects at the level of the microbiome. We aimed to evaluate the effect of A. muciniphila treatment on the endogenous community from four different donors in a validated, controlled in vitro model of the gut microbial ecosystem (SHIME). Taking into account the nutritional specificity of A. muciniphila, and the prebiotic-like action of mucins in the colon environment, the interplay between mucin, A. muciniphila and the endogenous community was investigated. The effects on the microbial community composition and functionality of A. muciniphila supplementation without mucin were limited, whereas mucin addition successfully induced compositional and metabolic changes in the gut microbiota. Indeed, mucin addition resulted in significantly higher acetate, propionate and butyrate production for all four donors, and the increase of several species, including A. muciniphila, Ruminococcus, Clostridium cluster XIVa, and Lachnospiraceae This study revealed that the supplementation of A. muciniphila together with mucin limited the observed prebiotic-like effect of mucin in inducing compositional changes.
Copyright © 2020 American Society for Microbiology.

Entities:  

Year:  2020        PMID: 33277271      PMCID: PMC7851700          DOI: 10.1128/AEM.02647-20

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  60 in total

1.  Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.

Authors:  Chin Wen Png; Sara K Lindén; Kristen S Gilshenan; Erwin G Zoetendal; Chris S McSweeney; Lindsay I Sly; Michael A McGuckin; Timothy H J Florin
Journal:  Am J Gastroenterol       Date:  2010-07-20       Impact factor: 10.864

2.  Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.

Authors:  Patrick D Schloss; Sarah L Westcott; Thomas Ryabin; Justine R Hall; Martin Hartmann; Emily B Hollister; Ryan A Lesniewski; Brian B Oakley; Donovan H Parks; Courtney J Robinson; Jason W Sahl; Blaz Stres; Gerhard G Thallinger; David J Van Horn; Carolyn F Weber
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

3.  Next-generation probiotics: the spectrum from probiotics to live biotherapeutics.

Authors:  Paul W O'Toole; Julian R Marchesi; Colin Hill
Journal:  Nat Microbiol       Date:  2017-04-25       Impact factor: 17.745

4.  Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies.

Authors:  Kequan Zhou
Journal:  J Funct Foods       Date:  2017-03-29       Impact factor: 4.451

5.  Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement.

Authors:  Maria Carlota Dao; Eugeni Belda; Edi Prifti; Amandine Everard; Brandon D Kayser; Jean-Luc Bouillot; Jean-Marc Chevallier; Nicolas Pons; Emmanuelle Le Chatelier; Stanislav Dusko Ehrlich; Joel Doré; Judith Aron-Wisnewsky; Jean-Daniel Zucker; Patrice D Cani; Karine Clément
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-02       Impact factor: 4.310

6.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.

Authors:  Amandine Everard; Clara Belzer; Lucie Geurts; Janneke P Ouwerkerk; Céline Druart; Laure B Bindels; Yves Guiot; Muriel Derrien; Giulio G Muccioli; Nathalie M Delzenne; Willem M de Vos; Patrice D Cani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

7.  Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem.

Authors:  K Molly; M Vande Woestyne; W Verstraete
Journal:  Appl Microbiol Biotechnol       Date:  1993-05       Impact factor: 4.813

Review 8.  A refined palate: bacterial consumption of host glycans in the gut.

Authors:  Angela Marcobal; Audrey M Southwick; Kristen A Earle; Justin L Sonnenburg
Journal:  Glycobiology       Date:  2013-05-28       Impact factor: 4.313

9.  The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes.

Authors:  Mark W J van Passel; Ravi Kant; Erwin G Zoetendal; Caroline M Plugge; Muriel Derrien; Stephanie A Malfatti; Patrick S G Chain; Tanja Woyke; Airi Palva; Willem M de Vos; Hauke Smidt
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

10.  Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.

Authors:  Annelies Geirnaert; Marta Calatayud; Charlotte Grootaert; Debby Laukens; Sarah Devriese; Guy Smagghe; Martine De Vos; Nico Boon; Tom Van de Wiele
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

View more
  3 in total

Review 1.  Intestinal Inflammation as a Dysbiosis of Energy Procurement: New Insights into an Old Topic.

Authors:  J Scott Lee; Ruth X Wang; Erica E Alexeev; Sean P Colgan
Journal:  Gut Microbes       Date:  2021 Jan-Dec

2.  Pasteurized Akkermansia muciniphila Ameliorate the LPS-Induced Intestinal Barrier Dysfunction via Modulating AMPK and NF-κB through TLR2 in Caco-2 Cells.

Authors:  Mengxuan Shi; Yunshuang Yue; Chen Ma; Li Dong; Fang Chen
Journal:  Nutrients       Date:  2022-02-11       Impact factor: 5.717

3.  Ecological Adaptation and Succession of Human Fecal Microbial Communities in an Automated In Vitro Fermentation System.

Authors:  Thiyagarajan Gnanasekaran; Juliana Assis Geraldo; David Wilczek Ahrenkiel; Camila Alvarez-Silva; Carmen Saenz; Adnan Khan; Obaida Hanteer; Vithiagaran Gunalan; Kajetan Trost; Thomas Moritz; Manimozhiyan Arumugam
Journal:  mSystems       Date:  2021-07-27       Impact factor: 6.496

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.